Wang Lining entered into an agreement to acquire 0.77% stake in Changchun Changsheng Life Sciences Limited from Wang Shiduo, Xu Lei, and Chen Gu for CNY 19.9 million on October 15, 2014. Wang Shiduo will transfer 0.47% stake in Changchun Changsheng to Wang Lining for CNY 12.15 million; Xu Lei will transfer 0.24% stake in Changchun Changsheng to Wang Lining for CNY 6.25 million; Chen Gu will transfer 0.06% stake in Changchun Changsheng to Wang Lining for CNY 1.5 million. Changchun Changsheng Life Sciences Limited reported total assets of CNY 1.56 billion, total owner's equity of CNY 1 billion, revenue of CNY 622.62 million, operating profit of CNY 236.68 million and net profit of CNY 207.86 million as of December 31, 2014.